American Healthcare REIT, Inc. AHR
52.02
(0.29)
(0.55%)
as of 25 Sep
- Market cap
- $11.5B
- P/E
- 76.5×
Follow AHR
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
76.69 | 81.31 | 114.78 | 300.07 |
+8 more quarters Free account |
P/S ratio |
4.02 | 3.73 | 3.46 | 3.23 | |
P/FCF ratio |
46.39 | 42.10 | 36.16 | 19.61 | |
P/Operating CF |
84.72 | 108.97 | 141.66 | 66.24 | |
P/B ratio |
2.69 | 2.51 | 2.33 | 2.61 | |
Price to Tangible BV |
3.07 | 2.91 | 2.72 | 3.08 | |
EV/Sales |
4.52 | 4.31 | 4.08 | 3.85 | |
EV/EBITDA |
25.67 | 24.67 | 23.69 | 22.02 | |
EV/Operating CF |
31.21 | 32.47 | 31.29 | 28.35 | |
EV/FCF |
52.16 | 48.72 | 42.64 | 23.40 | |
Quick Ratio |
0.48 | 0.45 | 0.41 | 0.44 | |
Current Ratio |
0.48 | 0.45 | 0.41 | 0.44 | |
Net Debt/EBITDA |
10.12 | 12.09 | 13.90 | 13.55 | |
Debt/Assets |
25.29% | 27.61% | 28.58% | 32.60% | |
Debt/Equity |
0.39 | 0.44 | 0.46 | 0.57 | |
Asset Turnover |
0.49 | 0.47 | 0.46 | 0.47 | |
Operating CF/Net income |
3.88 | 3.42 | 5.12 | 1.92 | |
Capex/Depreciation |
(0.50) | (0.50) | (0.69) | (0.38) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.95% | 2.71% | 2.74% | 2.46% | |
Intangible Assets out of Total Assets |
0.08 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.86% | 0.75% | 0.90% | 0.60% | |
Graham Net Nets |
(0.15) | (0.19) | (0.22) | (0.24) | |
Graham Number |
17.24 | 15.66 | 13.66 | 7.12 | |
Earnings Yield |
1.30% | 1.23% | 0.87% | 0.33% | |
Free Cash Flow Yield |
2.16% | 2.38% | 2.77% | 5.10% | |
Revenue per Share |
3.50 | 3.47 | 3.64 | 3.39 | |
Operating CF per Share |
0.62 | 0.43 | 0.33 | 0.63 | |
Capex per Share |
(0.21) | (0.20) | (0.27) | (0.13) | |
Free Cash Flow per Share |
0.41 | 0.23 | 0.06 | 0.50 | |
Cash per Share |
0.99 | 0.84 | 0.91 | 1.09 | |
Shareholders Equity per Share |
19.42 | 18.80 | 20.24 | 16.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.42 | 18.80 | 20.24 | 16.09 | |
Free Cash Flow |
78.24 | 42.75 | 10.66 | 84.99 | |
Working Capital |
(460.76) | (491.60) | (511.44) | (474.78) | |
Capital Expenditures |
(40.38) | (38.32) | (44.50) | (22.20) | |
Net Current Asset Value |
(1,540.77) | (1,678.82) | (1,709.54) | (1,677.39) | |
EV/EBIT |
70.54 | 62.26 | 56.26 | 50.82 | |
Capex to Sales |
0.06 | 0.06 | 0.07 | 0.04 | |
Net Profit Margin |
4.54% | 3.64% | 1.78% | 9.76% | |
Price to Operating Income |
62.73 | 53.80 | 47.72 | 42.60 | |
| Other line items | |||||
Average Receivables |
226.85 | 232.13 | 207.71 | 196.14 | |
Average Payables |
302.92 | 306.27 | 288.03 | 283.92 | |
Average Assets |
5,105.28 | 5,031.35 | 4,957.14 | 4,723.65 | |
Average Common Equity |
3,102.27 | 2,912.92 | 2,832.28 | 2,488.45 |
Columns are period end dates